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Abstract 
Background: Chinese men who have sex with men (MSM) rarely receive gonorrhea/chlamydia testing. The 
purpose of this pilot study was to evaluate a pay-it-forward strategy to increase gonorrhea/chlamydia testing 
among MSM. Pay-it-forward has one person receive a gift, then asks the same person if they would like to 
give a gift to another person. 
Methods: We used a quasi-experimental pragmatic study to compare a pay-it-forward model to standard of 
care at two HIV testing sites for MSM. A pay-it-forward program was implemented for three months, during 
which men were offered free gonorrhea/chlamydia testing and given the option of donating money toward 
testing for future participants. Both sites then switched to standard of care for three months, offering dual 
testing at the standard price. We compared test uptake and financial costs in the two groups. 
Findings: 408 men were included in this study. 203 men were offered pay-it-forward, and 205 were offered 
standard of care. Overall, 109 (109/203, 53·7%) men received gonorrhea/chlamydia testing in the pay-it-
forward group and 12 (12/205, 5·9%) men received gonorrhea/chlamydia testing in the standard of care 
group (adjusted odds ratio 19·73, 95%CI 10·02-38·85). This was a first gonorrhea or chlamydia test for 86% 
(104/121) of men. 89% (97/109) of men in the pay-it-forward group donated some amount. The incremental 
unit cost per test in the pay-it-forward group was 67 USD, compared to 503 USD in the standard of care 
group. 
Interpretation: Pay-it-forward may be a sustainable model for expanding integrated HIV testing services 
among MSM in China.  
Funding: National Institutes of Health, Southern Medical University Dermatology Hospital, Doris Duke 
Charitable Foundation 
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Research in context 
Evidence before this study 
In China, gonorrhea and chlamydia are common among MSM, but there have been few interventions to 
promote testing. We performed a PubMed search for “gonorrhea” or “chlamydia” with the terms “MSM,” 
“China,” and “testing” or “screening” or “intervention.” There were no date restrictions and the search was 
performed 15 June 2018. We identified two English language studies reporting rates of lifetime gonorrhea and 
chlamydia testing less than 50% among Chinese MSM. We also found one protocol for a randomized 
controlled trial to evaluate the impact of automated text message reminders on STD testing. We did not find 
other studies on interventions for gonorrhea or chlamydia testing among MSM in China. We also searched 
PubMed and Google Scholar using the terms “pay it forward” or “generalized reciprocity.” We found several 
studies examining the behavioral economics of pay-it-forward pricing schemes, but did not identify any 
studies investigating pay-it-forward as a promotional strategy or applying generalized reciprocity to public 
health.  
Added value of this study 
This study evaluated a pay-it-forward model for gonorrhea and chlamydia testing among Chinese MSM. We 
found that a pay-it-forward model substantially increased test uptake compared to the standard of care. The 
program reached many untested MSM and identified new positive cases. This expands the literature by 
formally evaluating a pay-it-forward program focused on improving health. 
Implications of all available evidence 
Our study identified a high percentage of previously untested MSM and a large burden of disease, 
highlighting the low test uptake and the need for improved gonorrhea and chlamydia testing for Chinese 
MSM. A pay-it-forward testing program may be a promising strategy for creating a sustainable program for 
integrated HIV/STD testing among key populations. 
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Introduction 
Gonorrhea and chlamydia are common STDs which spread rapidly and silently through communities of men 
who have sex with men (MSM). The prevalence of gonorrhea and chlamydia among Chinese MSM is as high 
as 10-20%.1,2 These two STDs are known to increase the risk of HIV acquisition3 and transmission,4 but are 
often asymptomatic at extragenital sites.5 WHO guidelines recommend regular gonorrhea and chlamydia 
testing for MSM.6 US Centers for Disease Control guidelines recommend testing at least once a year for all 
MSM, and more frequently for men with higher sexual risk.7 
However, few MSM in China receive gonorrhea and chlamydia testing. Previous studies suggest that less than 
half of MSM have ever received a gonorrhea or chlamydia test.8,9 This major missed public health opportunity 
is likely related to poor government support for testing programs,10 unlinked systems for HIV testing and 
other STDs,11,12 and insufficient community ownership. First, China has no screening guidelines for 
gonorrhea or chlamydia testing among MSM. There are also no widespread programs supporting gonorrhea 
and chlamydia testing.10 Second, the extensive HIV testing system in China is not integrated to facilitate other 
STD testing.11,12 Third, many advances in the HIV field have been catalyzed by input from MSM and civil 
society.13 China has relatively low MSM community ownership of health services, partly due to the persistent 
stigma.14 Existing community-based services and promotional campaigns are focused on HIV, with fewer 
services related to gonorrhea or chlamydia testing.15 
In response to this need, several community organizations organized a gonorrhea and chlamydia testing pilot 
program using a pay-it-forward model. Pay-it-forward has one person receive a gift, then asks the same 
person if they would like to give a gift to another person (Video).16,17 Pay-it-forward fits within the broader 
field of behavioral economics which uses multiple disciplines to understand human decision making. Pay-it-
forward chains of giving are sometimes driven by unconnected generous individuals,18 but more often 
organized by a group with a common purpose.19,20 Studies have shown that pay-it-forward can be sustainable 
and promote generosity.21  
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In this study, a pay-it-forward model was applied to paying for dual gonorrhea/chlamydia testing at two free 
HIV/syphilis testing sites for MSM. Program organizers contributed an initial pool of funding, and MSM at 
these sites were offered a free gonorrhea/chlamydia test with the option to contribute toward testing for 
future participants. The purpose of this quasi-experimental study is to evaluate a pay-it-forward intervention 
on gonorrhea and chlamydia testing among Chinese MSM.  
 
Methods 
Setting  
The study was undertaken in Guangzhou, China at two sites – an STD clinic for MSM and a local MSM 
community-based organization (CBO). The STD clinic site was embedded in an outpatient clinic; the CBO 
site operated within a CBO office in the community. These two sites were chosen because they were 
developed with strong input from MSM and provided free HIV/syphilis testing to all MSM. Both sites were 
staffed by MSM volunteers, nurses, and public health staff. There were no clinical doctors at either site. Blood 
draws, testing, results reporting, and follow-up of HIV and syphilis tests were handled by staff at each site. 
Both sites followed the same study procedures (Appendix, page 2).  
Study design 
This study was designed as a quasi-experimental pragmatic trial at the two sites. We chose a pragmatic design 
in order to evaluate this program in a real-life context to benefit MSM in Guangzhou. A quasi-experimental 
study involves evaluating an intervention without the use of randomization.22 In this study, we evaluated the 
pay-it-forward intervention model against a standard of care control (Fig 1). The pay-it-forward program was 
implemented December 2017 to February 2018 and the standard of care was implemented March 2018 to 
May 2018.  
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Pay-it-forward program  
The pay-it-forward intervention was developed through crowdsourcing in three ways: (1) an open challenge 
contest23 was used to develop the name and style of the program materials; (2) at the CBO site, hand-written 
notes from previous participants in the program encouraged testing for future participants; (3) community 
volunteers helped organize the program. At both of the program sites, MSM who were waiting for HIV and 
syphilis testing were offered dual gonorrhea/chlamydia testing (Appendix, page 2). First, men were provided 
a brief (5 minute) introduction to gonorrhea and chlamydia testing using a pamphlet (Appendix, page 3). 
Program organizers then explained the pay-it-forward program, including the purpose (to promote 
gonorrhea/chlamydia testing), the opportunity to receive free gonorrhea and chlamydia tests, and the 
voluntary decisions to test and to contribute money (Appendix, page 4). Men were told that the patient price 
of gonorrhea and chlamydia testing was 150 RMB ($24 USD), but previous men attending the clinic had 
donated money to cover this cost. Thus, each man could receive a free gonorrhea and chlamydia test, then 
decide whether to donate money (pay-it-forward) for future men to receive the same option. Men were 
assured that donating was completely optional and advised to pay any amount that was feasible for them. 
Each man’s gonorrhea and chlamydia test fees were covered by a combination of the initial funding pool 
from the program organizers and the donations from previo408 us participants. At the CBO site, men were 
also shown a postcard with a message written by a previous pay-it-forward contributor and told that they 
could also write a postcard message for a future participant (Appendix, page 4). Men then decided whether or 
not to receive combined gonorrhea/chlamydia testing. All men were asked to fill out a brief survey about 
their sexual history, testing history, and attitudes toward the testing program, regardless of whether or not 
they tested.  
MSM who received testing were asked about sexual practices (oral, anal receptive, anal insertive) and advised 
to receive pharyngeal, anal, or urethral testing. All participants were informed that their information would be 
kept confidential, and results would be sent to them in one week. Men who agreed to participate either had a 
nurse collect the sample (STD clinic site) or self-collected the sample (CBO site).24 At the STD clinic site, 
samples were immediately delivered to the laboratory. Self-collected samples from the CBO site were stored 
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at room temperature overnight, then transported to the Southern Medical University Dermatology Hospital 
for laboratory testing. Program organizers informed participants of their test results via WeChat, a popular 
messaging application with monetary transfer functionality. Men with positive test results were counseled and 
directed to the WeChat page of Southern Medical University Dermatology Hospital where they could make 
an appointment to receive treatment and follow-up. Counseling included information about condom use, safe 
sexual practices, and the importance of testing.  
Standard of care 
During the standard of care period, men were offered gonorrhea and chlamydia testing at the standard patient 
price. All men were provided a brief introduction about gonorrhea and chlamydia testing using the same 
pamphlet, but did not receive the explanation about pay-it-forward or view the associated postcards 
(Appendix, page 2). 
Laboratory testing 
All urine and anal swab samples were analyzed at Southern Medical University Dermatology Hospital using 
Cobas 4800 CT/NG DNA detection kits (Roche Diagnostics, Basel, Switzerland). At the STD clinic site, 
HIV testing was performed using the Diagnostic Kit for Antibody to HIV ½ (Abon Pharmaceuticals, 
Northvale, New Jersey, USA) and syphilis testing was performed using the Treponema Pallidum Antibodies 
Rapid Test (Abon Pharmaceuticals, Northvale, New Jersey, USA). At the CBO site, HIV testing was 
performed using the Third Generation Diagnostic Kit for Antibody to HIV rapid test (InTec, Xiamen, 
China ) and syphilis testing was performed using the Syphilis Antibody (anti-Treponema Pallidum) rapid test 
(InTec, Xiamen, China).  
Data collection 
We extracted data from all MSM who were approached regarding gonorrhea/chlamydia testing. Program 
organizers compared the collected WeChat social media IDs of the men in order to identify men who tested 
more than once; these men were excluded from the analysis. The primary outcome for this study was uptake 
of dual gonorrhea/chlamydia testing. This was defined based on laboratory receipt of a sample and return of 
8 
 
results to the man. For each participant in the pay-it-forward arm, we recorded the amount that they 
contributed to the next participant.  
The survey instrument collected data on sociodemographic characteristics, including age, education, marital 
status, income; data on sexual behavior including previous sex with men, role in anal sex (primarily insertive, 
primarily receptive, or about half and half), condomless anal sex in the past three months, and number of sex 
partners in the past three months; previous HIV testing, gonorrhea testing, and chlamydia testing. For both 
groups, we collected information on reasons for accepting or declining gonorrhea and chlamydia testing 
(Appendix, page 5). Among men who received testing in the pay-it-forward group, the most commonly cited 
reason was the pay-it-forward program (49/102, 48%). For the pay-it-forward group, we also asked about 
perceived benefits and barriers of the pay-it-forward program (Appendix, page 6).  
We collected HIV and syphilis test results for all participants, as well as gonorrhea and chlamydia test results 
for those tested.  
Data analysis 
Our main hypothesis was that the pay-it-forward program would increase dual gonorrhea/chlamydia test 
uptake compared to the standard of care. This hypothesis was pre-specified during study design. We used 
descriptive statistics to examine demographic and behavioral characteristics of MSM. We compared the 
gonorrhea/chlamydia testing rate between the pay-it-forward model and the standard of care model using 
chi-squared test and logistic regression, reported as crude odds ratios (cOR) and adjusted odds ratios (aOR), 
by adjusting for nationality, marital status, income, and site of testing. We chose these covariates because they 
are potential confounders. We also calculated incremental unit costs per gonorrhea/chlamydia test and per 
gonorrhea/chlamydia diagnosis. We first calculated the total financial cost for each group, then divided these 
costs by the number of men tested and by the number of men diagnosed in each group. All data were 
analyzed using SAS version 9·4 (SAS Institute, Cary, NC, USA). 
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Ethics and Role of the Funding Source 
Ethical approval for this study was obtained from the institutional review board at the University of North 
Carolina at Chapel Hill. The sponsor of the study had no role in study design, data collection, data analysis, 
data interpretation, or writing of the report. The corresponding author had full access to all the data in the 
study and had final responsibility for the decision to submit for publication. 
Results 
From December 2017 to May 2018, we approached a total of 447 participants across the two clinics. One 
man who received testing through both groups was excluded from our analysis. 408 were included in the 
analysis, 161 from the STD clinic and 247 from the CBO site. We analyzed data from 203 men who were 
offered pay-it-forward testing and 205 who were offered the standard of care (Fig 1).  
Participant characteristics 
Demographic characteristics were similar between the pay-it-forward group and the standard of care group 
(Table 1). The majority of participants were aged 30 or younger (75%), of Han ethnicity (95%), had a 
bachelor’s degree or above (67%), and had never married (90%), and had a monthly income of USD $1582 
(10,000 RMB) or below (81%). 65% reported ever disclosing their sexual orientation to family, friends, or 
healthcare professionals. 37% of participants reported condomless anal sex within the past three months, and 
5% reported a female partner in the past three months. 76% had previously tested for HIV, while 16% had 
previously tested for gonorrhea and 11% had previously tested for chlamydia. 
Gonorrhea/chlamydia testing uptake and test results  
Fig 2 shows the gonorrhea/chlamydia test uptake in the pay-it-forward versus standard of care groups. 
Overall, 109 (109/203, 53·7%) men received gonorrhea/chlamydia testing in the pay-it-forward group and 12 
(12/205, 5·9%) men received gonorrhea/chlamydia testing in the standard of care group (adjusted 
OR=19·73, 95%CI 10·02-38·85).  Testing uptake rates were similar at the STD clinic and CBO sites.  
Multivariable regression models adjusting for marital status, education, income, and study site showed that 
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the odds of receiving a gonorrhea/chlamydia test were significantly higher in the pay-it-forward group 
compared to the standard of care (aOR = 19·73, 95% CI 10·02-38·85, p< 0·0001, Table 2).  
This was a first gonorrhea test for 97/121 men (80%) and a first chlamydia test for 104/121 men (86%). Five 
men (4%) were diagnosed with gonorrhea and 15 (12%) were diagnosed with chlamydia. 16/408 men (4%) 
were diagnosed with HIV and 4/408 (1%) with syphilis.  
Attitudes toward testing and pay-it-forward 
Within the pay-it-forward group, 49/102 (49%) participants reported that their primary reason for getting 
tested was the pay-it-forward program (Appendix, page 5). In both groups, the most common reasons for not 
testing were “I don’t need to get tested” and “I don’t know about gonorrhea and chlamydia” (Appendix, page 
5). The most commonly cited benefits of the pay-it-forward program were awareness of one’s own health 
status, increasing testing among the MSM community, and reciprocal giving (Appendix, page 6).  
Pay-it-forward contributions 
Of the 109 MSM who received testing through pay-it-forward, 97 (89%) chose to contribute some amount. 
The average donation per participant was 64·84 RMB ± 56·92 ($10 USD). The largest donation was 200 
RMB ($32 USD) and the median donation was 50 RMB ($8 USD) (Appendix, page 7). Additionally, four men 
who did not receive gonorrhea/chlamydia testing contributed a total of 470 RMB ($75 USD).  
Costing analysis 
The incremental unit cost per gonorrhea/chlamydia test in the pay-it-forward group was 67 USD, compared 
to 503 USD in the standard of care group (87% reduction). The incremental cost per newly diagnosed 
gonorrhea or chlamydia infection was 456 USD in the pay-it-forward group and 1210 USD in the standard of 
care group (70% reduction) (Fig 3).  
 
Discussion                                                                                                                                                                                                              
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Low STD testing rates represent a major missed public health opportunity among MSM in China. We 
evaluated a pay-it-forward STD testing model and found that the model substantially increased test uptake 
compared to the standard of care. From a financial perspective, most of the costs associated with testing were 
supported by local MSM, suggesting a viable pathway to sustainable service delivery. 
Our data shows that pay-it-forward can increase gonorrhea/chlamydia testing uptake. 54% of participants in 
the pay-it-forward group received gonorrhea/chlamydia testing, and about half of participants reported that 
the main reason for testing was the pay-it-forward program. We were unable to find literature demonstrating 
that pay-it-forward increases service uptake. Pay-it-forward programs are usually presented to individuals who 
have already committed to purchasing the services. Increased STD testing may be related to reduced testing 
fees, increased community engagement, or contagious kindness. Men participating in the pay-it-forward 
program did not have to pay for gonorrhea/chlamydia testing and the small fee associated with testing may 
be a barrier to testing. Second, the pay-it-forward spurred community engagement by actively engaging MSM 
in the development and implementation of the service. Previous studies have shown that community 
engagement in sexual health is associated with increased HIV testing among MSM.25 Finally, by participating 
in the program, pay-it-forward participants receive not only the test, but also the benefit of feeling cared for 
by others and the opportunity to help others.26 Most men in the pay-it-forward group reported that getting 
other MSM to test or helping someone else were benefits of pay-it-forward. This is consistent with research 
showing that generous behavior can spread through communities.27  
The pay-it-forward program reached a subset of high-risk, untested MSM. Among all MSM who tested, this 
was the first gonorrhea or chlamydia test for 80% and 86%, respectively. Overall, we identified 5 cases (4%) 
of gonorrhea and 15 cases (12%) of chlamydia. This is consistent with prevalence rates from a previous study 
of MSM in Guangzhou.2  Previous studies have evaluated and recommended combined HIV and syphilis 
testing.11,28 Our study extends this literature by demonstrating a feasible approach for integrating 
gonorrhea/chlamydia testing with HIV testing.   
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Among testers in the pay-it-forward group, 89% (98/109) chose to donate to future men. The average 
donation was $10 USD. This is notable and suggests that MSM are willing to invest in their healthcare despite 
accessing free HIV and syphilis testing services. In our program, we initially invested enough funding for 81 
tests. 31 additional tests were covered entirely by contributions from previous testers, and at the end of the 
program period, there remained funding for 19 more tests. Compared to free testing, a pay-it-forward model 
can increase the number of available tests by distributing part of the cost to test recipients without making 
cost a barrier to access.29 From an implementation perspective, a pay-it-forward model that combines 
institutional funding with patient contributions could allow a limited amount of funding to go a longer way.30 
Future programmatic efforts can investigate ways to make a pay-it-forward gonorrhea/chlamydia testing 
program independent and self-sustaining.  
Our study has implications for research and implementation. The concept of pay-it-forward has often been 
used as a promotional tool,19-21 but its application to public health is novel. Future research should analyze the 
cost-effectiveness of pay-it-forward, as well as evaluate pay-it-forward in a randomized controlled trial over a 
longer duration of time. Qualitative research on understanding the motivations and optimal implementation 
may also be helpful.  Our preliminary findings suggest that a pay-it-forward model may be an effective tool in 
promoting screening and has potential in creating a self-sustaining service. We did not find differences 
between test uptake rates at the two sites despite some differences in implementation, suggesting that pay-it-
forward programs may be feasible across multiple settings. In low and middle-income countries, there is 
limited funding for many screening and preventive health services.30 Pay-it-forward may be a useful tool in 
promoting and funding these essential services.  
Several important limitations merit discussion. First, this study is limited by its quasi-experimental design 
which prevents us from making direct inferences about causality. There may have been other unmeasured 
differences between the two groups. However, the two groups of men were similar in terms of socio-
demographic and behavioral characteristics. Second, the pay-it-forward program was only piloted at two sites 
in Guangzhou aimed at HIV/syphilis testing for MSM. This limited our analysis to MSM who were already 
connected with community-based organizations willing to receive an HIV test. Third, the pay-it-forward 
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intervention included both free testing and creating a sense of moral obligation to contribute to the health of 
other gay men. Our study could not differentiate to what extent these two factors individually contributed to 
the success of the program. Finally, the success of the program may vary depending on how embedded they 
are in a trusted MSM service. Although both sites showed similar rates of gonorrhea/chlamydia testing, both 
sites are trusted by the Guangzhou MSM community. It is not known whether such a program would be 
successful in other settings or among other populations, and further research is needed.  
Conclusion 
We evaluated a pay-it-forward model applied to preventive health services. We found high uptake of 
gonorrhea and chlamydia testing through the pay-it-forward program compared to the standard of care, 
suggesting that it is a useful tool for increasing testing uptake among MSM. In our study, the majority of 
testers were first-time testers of gonorrhea and chlamydia, and the program identified a substantial number of 
positive cases. Our results suggest that pay-it-forward may be a useful strategy for promoting public health 
services, leveraging contagious kindness to spur health.  
 
 
Contributors 
JDT conceived the study. KTL, WT, SWP and JDT designed the study. KTL, DW, WH, FW, AL, and HF 
coordinated and conducted the study. YLG secured funding and assisted with program logistics for the study. 
WT, LH and VM contributed ideas for study design and analysis. KTL, WT and JDT developed the analysis 
plan, and KTL analyzed the data. KTL and JDT wrote the first draft of the manuscript. All authors edited 
and approved the final draft for submission.  
Declaration of interests  
JDT and WT are on the advisory board for SESH Global, which was involved in organizing the study. All 
other authors declare no competing interests 
14 
 
Acknowledgments 
The National Institutes of Health (NIAID R01AI114310), the Southern Medical University Dermatology 
Hospital, and the Doris Duke Charitable Foundation funded the study. We would also like to thank Weizan 
Zhu and Yang Zhang for their help with program coordination, Yang Zhao and Thomas Fitzpatrick for their 
help with program execution, and Yaohua Xue, Wujian Ke , and Liyan Yuan from SMU Dermatology 
Hospital for sample processing. Thanks to Kevin Cao for creating the video explaining pay-it-forward. We 
would like to thank Nicholas Christakis and the Yale Institute of Network Sciences for providing comments 
on an earlier version of this manuscript. We would also like to acknowledge all participants of the pay-it-
forward program.  
 
  
15 
 
References 
1. Chen X-S, Peeling RW, Yin Y-P, Mabey DC. The epidemic of sexually transmitted infections in China: implications for control and 
future perspectives. BMC Med 2011; 9(1): 111. 
2. Yang L, Zhang X, Chen Z, et al. O17.1 Prevalence of neisseria gonorrhoeae and chlamydia trachomatis infections in different 
anatomic sites among men who have sex with men: results of 380 msm who attended a std clinic in guangzhou, china. Sex Transm 
Infect 2017; 93(Suppl 2): A38. 
3. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased 
risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53(4): 537-43. 
4. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications 
for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349(9069): 1868-73. 
5. Detels R, Green AM, Klausner JD, et al. The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia trachomatis 
and Neisseria gonorrhoeae Infections in Selected Populations in Five Countries. Sex Transm Dis 2011; 38(6): 503-9. 
6. WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and 
transgender people. 2011. Geneva, Switzerland. http://www.who.int/hiv/pub/guidelines/msm_guidelines2011/en/ 
7. CDC. 2015 Sexually Transmitted Diseases Treatment Guidelines. 2015. https://www.cdc.gov/std/tg2015/screening-
recommendations.htm. 
8. Lin L, Nehl EJ, Tran A, He N, Zheng T, Wong FY. Sexually transmitted infection testing practices among ‘money boys’ and 
general men who have sex with men in Shanghai, China: objective versus self-reported status. Sex Health 2014; 11(1): 94-6. 
9. Davis A, Best J, Luo J, et al. Risk behaviours, HIV/STI testing and HIV/STI prevalence between men who have sex with men and 
men who have sex with both men and women in China. Int J STD AIDS 2016; 27(10): 840-9. 
10. Zheng N, Guo Y, Padmadas S, Wang B, Wu Z. The increase of sexually transmitted infections calls for simultaneous preventive 
intervention for more effectively containing HIV epidemics in China. BJOG 2014; 121(s5): 35-44. 
11. Tucker JD, Yang L-G, Yang B, et al. A Twin Response to Twin Epidemics: Integrated HIV/Syphilis Testing at STI clinics in 
South China. J Acquir Immune Defic Syndr 2011; 57(5): e106-e11. 
12. Ong JJ, Fu H, Pan S, et al. Missed opportunities for HIV and syphilis testing among men who have sex with men in China: a 
cross-sectional study. Sex Transm Dis 2018; 45: 382-386. 
13. Trapence G, Collins C, Avrett S, et al. From personal survival to public health: community leadership by men who have sex with 
men in the response to HIV. Lancet 2012; 380(9839): 400-10. 
14. Neilands TB, Steward WT, Choi KH. Assessment of stigma towards homosexuality in China: a study of men who have sex with 
men. Arch Sex Behav 2008; 37(5): 838-44. 
15. Cheng W, Cai Y, Tang W, et al. Providing HIV-related services in China for men who have sex with men. Bull World Health Organ 
2016; 94(3): 222-7. 
16. Chiang Y-S, Takahashi N. Network Homophily and the Evolution of the Pay-It-Forward Reciprocity. PloS One 2011; 6(12): 
e29188. 
17. Hyde CR. Pay It Forward. New York, NY: Simon & Schuster; 1999. 
18. Murphy K. Ma'am, Your Burger Has Been Paid For. The New York Times. 2013 October 19, 2013. 
19. Cueva M. Thanks, au lait: 750 pay it forward at Starbucks location. CNNcom. 2014 August 22, 2014. 
20. Wegert T. JetBlue Pays It Forward Through a Social Storytelling Campaign With No End in Sight. The Content Strategist. 2014 
November 13th, 2014. 
21. Jung MH, Nelson LD, Gneezy A, Gneezy U. Paying more when paying for others. J Pers Soc Psychol 2014; 107(3): 414-31. 
22. Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Chicago: Rand McNally; 1979. 
23. Tucker JD, Fenton KA. Innovation challenge contests to enhance HIV responses. Lancet HIV 2018; 5(3): e113-e5. 
24. Yared N, Horvath K, Fashanu O, Zhao R, Baker J, Kulasingam S. Optimizing screening for sexually transmitted infections in en 
using self-collected swabs - a systematic review. Sex Transm Dis 2017. 
25. Zhang TP, Liu C, Han L, et al. Community engagement in sexual health and uptake of HIV testing and syphilis testing among 
MSM in China: a cross-sectional online survey. J Int AIDS Soc 2017; 20(1): 21372. 
26. Gneezy A, Gneezy U, Nelson LD, Brown A. Shared Social Responsibility: A Field Experiment in Pay-What-You-Want Pricing 
and Charitable Giving. Science 2010; 329(5989): 325. 
27. Fowler JH, Christakis NA. Cooperative behavior cascades in human social networks. Proceedings of the National Academy of Sciences 
2010; 107(12): 5334. 
28. Tucker JD, Walensky RP, Yang L-G, et al. Expanding Provider-Initiated HIV Testing at STI Clinics in China. AIDS Care 2012; 
24(10): 1316-9. 
29. Sepehri A, Chernomas R. Are user charges efficiency‐ and equity‐enhancing? A critical review of economic literature with 
particular reference to experience from developing countries. Journal of International Development 2001; 13(2): 183-209. 
30. Howard LM. Public and private donor financing for health in developing countries. Infect Dis Clin North Am 1991; 5(2): 221-34. 
 
  
16 
 
Table 1: Participant characteristics by experimental condition. Shown as n (%).  
 
Pay-it-forward  
(n = 203) 
Standard of Care 
(n = 205) 
P-value# 
Age   0·69 
30 or under 153 (75%) 158 (77%)  
over 30 50 (25%) 47 (23%)  
Nationality   0·79 
Han Chinese 194 (96%) 197 (96%)  
Other 9 (4%) 8 (4%)  
Marital Status   0·08 
Never married 177 (88%) 191 (93%)  
Ever married 24 (12%) 14 (7%)  
Education   0·89 
Below Bachelor’s 66 (33%) 68 (33%)  
Bachelor’s and above 137 (67%) 137 (67%)  
Monthly income (USD)   0·80 
$0-157·27 24 (12%) 27 (13%)  
$157·28-786·36  64 (32%) 58 (29%)  
$786·37-1572·72 77 (39%) 78 (39%)  
> $1572·72 34 (17%) 39 (19%)  
Disclosure as MSM   0·10 
Never 77 (38%) 62 (30%)  
Ever 126 (62%) 143 (70%)  
Average No. male 
partners in last 3 
months* 1·90±2·02 1·70±1·57 0·27 
Female partner in last 3 
months   0·49 
No 191 (94%) 196 (96%)  
Yes 12 (6%) 9 (4%)  
Position w/ male 
partner   1·00 
Primarily insertive 59 (31%) 62 (31%)  
About half and half 64 (33%) 68 (34%)  
Primarily receptive 68 (36%) 72 (35%)  
Condomless anal sex in 
past 3 months   0·57 
No 130 (65%) 127 (62%)  
Yes 71 (35%) 78 (38%)  
Previously tested for 
HIV   0·27 
No 54 (27%) 45 (22%)  
Yes 149 (73%) 160 (78%)  
Previously tested for 
gonorrhea or chlamydia   0·86 
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No 168 (83%) 171 (83%)  
Yes 35 (17%) 34 (17%)   
*Shown as mean ± standard deviation. #Chi-squared test.  
 
 
 
Table 2: Proportion of people tested for chlamydia/gonorrhea in the control and intervention groups among 
gay men in Guangzhou, China (N=408) 
  N  
MSM who received 
gonorrhoea/chlamydia testing 
(%) 
Crude Odds Ratio 
(95% CI) 
Adjusted Odds Ratio (95% 
CI) 
Standard of care 205 12 (5·9%) Ref Ref 
Pay-it-forward 203 109 (53·9%) 18·65 (9·78, 35·54) 19·74 (10·03, 38·85)* 
    18·43 (9·48, 35·84)€ 
    19·73 (10·02, 38·85)£ 
Note: *Model adjusted for age, nationality, marital status, income and site of testing; €model adjusted for age, nationality, marital status and site of 
testing; £ model adjusted for nationality, marital status, income and site of testing. 
 
 
Video Legend 
Video summary of pay-it-forward. 
 
Figure Legends 
 
Fig 1: Study flow chart. The study used a quasi-experimental design. The intervention took place from 
December 2017 to February 2018, and the standard of care control took place from March 2018 to May 
2018.  
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Fig 2: Gonorrhea/chlamydia testing uptake in the intervention versus standard of care groups, n = 
408. Multivariable regression adjusted for age, nationality, marital status, education, income, and site of test 
showed aOR = 19·73, 95% CI 10·02-38·85, P < 0·0001.  
Fig 3: Incremental unit cost per gonorrhea/chlamydia test (left) and gonorrhea/chlamydia 
diagnosis (right).  
 
